Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesAdalimumab in ulcerative colitis: Two cases of mucosal healing and clinical response at two years
World Journal of Gastroenterology, 08/17/09
Barreiro–De AM et al. – Infliximab (IFX) is currently the only biologic therapy used in the treatment of moderate–to–severe ulcerative colitis (UC). In the years to come, more biologic therapies will have a role in the management of moderate–to–severe UC.
Related Articles
Medical Management of Ulcerative Colitis
Digestive Diseases, 11/09/09
Relevance Score: 70%
Oxidized Form Of A Common Vitamin May Bring Relief For Ulcerative Colitis
ScienceDaily, 10/02/09
Relevance Score: 69%
Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab
Gastroenterology, 10/06/09
Relevance Score: 68%
Leukocyte apheresis in the management of ulcerative colitis
Saudi Journal of Gastroenterology, 10/05/09
Relevance Score: 68%
Ulcerative Colitis Treatment Reduces Need For Surgery By Almost Half, Study Suggests
ScienceDaily, 10/02/09
Relevance Score: 68%
Today in Inflammatory Bowel Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of exclusive enteral nutrition on bone turnover in children with Crohn's disease
Journal of Gastroenterology, 12/10/09
Evolving paradigms in the pathogenesis of IBD
Journal of Gastroenterology, 12/10/09
Insights into IBD pathogenesis
Current Gastroenterology Reports, 12/09/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Methylnaltrexone: a subcutaneous treatment for opioid-induced constipation in palliative care patients
International Journal of Palliative Nursing, 12/10/09
Predictors of gastroduodenal erosions in patients taking low-dose aspirin
Alimentary Pharmacology and Therapeutics, 12/10/09
A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism
Alimentary Pharmacology and Therapeutics, 12/10/09
Sponsor
Article Search
Sponsor